What did Bayer receive from the European Medicines Agency?

Bayer won an endorsement from the European Medicines Agency to extend the intervals between shots of its anti-blindness treatment Eylea.

What is the recommended interval for Eylea injections?

The European Medicines Agency recommended that Eylea, at a high dose of 8 mg, can be injected at intervals of up to six months.

What condition does Eylea treat?

Eylea is used to treat wet age-related macular degeneration, a condition that can lead to blindness.

Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Headlines > Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals

Headlines

Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals

Published by Global Banking & Finance Review®

Posted on May 23, 2025

1 min read

Last updated: January 23, 2026

Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals - Headlines news and analysis from Global Banking & Finance Review

Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals

Quick Summary

Bayer Secures EU Approval for Extended Eylea Treatment Intervals

Key Takeaways

Frequently Asked Questions about Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals